Brian Holmes is the first man in the UK and the fifth in the world to receive the treatment.
MedPage Today on MSN
Study questions use of prostate cancer hormone therapy in certain cases
Adding hormone therapy to postoperative radiotherapy did not improve OS for most patients ...
Learn how Huntsman Cancer Institute uses cutting‑edge diagnostics and personalized care to treat early‑stage prostate cancer.
A meta-analysis explores whether there’s a survival benefit to adding hormone therapy to postoperative radiation for patients with low PSA levels.
MARCAP investigators conducted the first individual patient data meta-analysis of randomized trials (POSEIDON) evaluating the use and duration hormone therapy with postoperative radiation therapy in ...
Although immunotherapy progress in prostate cancer has been slow, emerging strategies like bispecific T-cell engagers (BiTEs) show promise in overcoming historical resistance. In a recent discussion, ...
Radiation therapy (also called radiotherapy) uses high-energy beams or subatomic particles to damage the DNA inside prostate cancer cells. After enough damage, the cells cannot multiply, and they die.
The 2026 European Association of Urology (EAU) annual meeting featured an advancing prognostics and therapeutics in ...
Prostate cancer is the most common cancer in men throughout the United States. Most men do not realize they have cancer due ...
Scans that make prostate cancer cells glow can eliminate the need for invasive biopsies and cut false positive—and they're ...
Australian scientists say it could also help reduce the risk of overdiagnosis by determining which cancers are low-risk and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results